BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36601349)

  • 1. The des-Arg
    Mendes GMM; Do Nascimento IJB; Marazzi-Diniz PH; Da Silveira IB; Itaborahy MF; Viana LE; Silva FA; Santana MF; Pinto RA; Dutra BG; Lacerda MVG; Araujo SA; Wanderley D; Vidigal PV; Diniz PH; Verano-Braga T; Santos RA; Leite MF
    Front Physiol; 2022; 13():1080837. PubMed ID: 36601349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
    Nicolau LAD; Magalhães PJC; Vale ML
    Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An interaction of renin-angiotensin and kallikrein-kinin systems contributes to vascular hypertrophy in angiotensin II-induced hypertension: in vivo and in vitro studies.
    Ceravolo GS; Montezano AC; Jordão MT; Akamine EH; Costa TJ; Takano AP; Fernandes DC; Barreto-Chaves ML; Laurindo FR; Tostes RC; Fortes ZB; Chopard RP; Touyz RM; Carvalho MH
    PLoS One; 2014; 9(11):e111117. PubMed ID: 25369284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive mass spectrometric determination of kinin-kallikrein system peptides in light of COVID-19.
    Gangnus T; Burckhardt BB
    Sci Rep; 2021 Feb; 11(1):3061. PubMed ID: 33542252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis for kinin selectivity and activation of the human bradykinin receptors.
    Yin YL; Ye C; Zhou F; Wang J; Yang D; Yin W; Wang MW; Xu HE; Jiang Y
    Nat Struct Mol Biol; 2021 Sep; 28(9):755-761. PubMed ID: 34518695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19.
    Martens CP; Van Mol P; Wauters J; Wauters E; Gangnus T; Noppen B; Callewaert H; Feyen JHM; Liesenborghs L; Heylen E; Jansen S; Pereira LCV; Kraisin S; Guler I; Engelen MM; Ockerman A; Van Herck A; Vos R; Vandenbriele C; Meersseman P; Hermans G; Wilmer A; Martinod K; Burckhardt BB; Vanhove M; Jacquemin M; Verhamme P; Neyts J; Vanassche T
    EBioMedicine; 2022 Sep; 83():104195. PubMed ID: 35939907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
    Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C
    Front Immunol; 2020; 11():2014. PubMed ID: 32849666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of biologically active kinin peptides, Met-Lys-bradykinin and Leu-Met-Lys-bradykinin from human kininogens by two major secreted aspartic proteases of Candida parapsilosis.
    Bras G; Bochenska O; Rapala-Kozik M; Guevara-Lora I; Faussner A; Kamysz W; Kozik A
    Peptides; 2013 Oct; 48():114-23. PubMed ID: 23954712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19?
    Gouda AS; Mégarbane B
    Drug Dev Res; 2021 Feb; 82(1):38-48. PubMed ID: 32761647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2+ signalling of kinins in cells expressing rat, mouse and human B1/B2-receptor.
    Zubakova R; Gille A; Faussner A; Hilgenfeldt U
    Int Immunopharmacol; 2008 Feb; 8(2):276-81. PubMed ID: 18182240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that kinin B2 receptor expression is upregulated by endothelial overexpression of B1 receptors.
    Rodrigues ES; Silva RF; Martin RP; Oliveira SM; Nakaie CR; Sabatini RA; Merino VF; Pesquero JB; Bader M; Shimuta SI
    Peptides; 2013 Apr; 42():1-7. PubMed ID: 23306173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted LC-MS/MS platform for the comprehensive determination of peptides in the kallikrein-kinin system.
    Gangnus T; Burckhardt BB
    Anal Bioanal Chem; 2021 May; 413(11):2971-2984. PubMed ID: 33693976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talk between carboxypeptidase M and the kinin B1 receptor mediates a new mode of G protein-coupled receptor signaling.
    Zhang X; Tan F; Brovkovych V; Zhang Y; Skidgel RA
    J Biol Chem; 2011 May; 286(21):18547-61. PubMed ID: 21454694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B₁ receptor in breast cancer cells.
    Ehrenfeld P; Manso L; Pavicic MF; Matus CE; Borquez C; Lizama A; Sarmiento J; Poblete MT; Bhoola KD; Naran A; Figueroa CD
    Anticancer Res; 2014 Dec; 34(12):6925-38. PubMed ID: 25503118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin and the kallikrein-kinin systems.
    Campbell DJ
    Int J Biochem Cell Biol; 2003 Jun; 35(6):784-91. PubMed ID: 12676165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EVIDENCE FROM FATAL COVID-19 FOR TARGETING THE BRADYKININ METABOLISM-A SINGLE-CENTER COHORT STUDY.
    Zinn S; Talbot SR; Rajapakse D; Ruskowski K; Neb H; Adam EH; von Knethen A; Zacharowski K; Heinicke U
    Shock; 2023 Dec; 60(6):727-738. PubMed ID: 37878473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive insight into the role of zinc deficiency in the renin-angiotensin and kinin-kallikrein system dysfunctions in COVID-19 patients.
    Gouda AS; Adbelruhman FG; Elbendary RN; Alharbi FA; Alhamrani SQ; Mégarbane B
    Saudi J Biol Sci; 2021 Jun; 28(6):3540-3547. PubMed ID: 33746538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does hereditary angioedema make COVID-19 worse?
    Xu Y; Liu S; Zhang Y; Zhi Y
    World Allergy Organ J; 2020 Sep; 13(9):100454. PubMed ID: 32834893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of kinin B1 receptor and the effect of angiotensin I-converting enzyme inhibition on acute gout attacks in rodents.
    Silva CR; Oliveira SM; Hoffmeister C; Funck V; Guerra GP; Trevisan G; Tonello R; Rossato MF; Pesquero JB; Bader M; Oliveira MS; McDougall JJ; Ferreira J
    Ann Rheum Dis; 2016 Jan; 75(1):260-8. PubMed ID: 25344431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.